Compugen Ltd. (TLV:CGEN)
Israel · Delayed Price · Currency is ILS · Price in ILA 533.00
-10.90 (-2.00%)
Feb 5, 2026, 5:27 PM IDT
Compugen Market Cap
Compugen has a market cap or net worth of 503.86 million as of February 5, 2026. Its market cap has decreased by -30.22% in one year.
Market Cap
503.86M
Enterprise Value
246.46M
Revenue
22.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
533.00
Market Cap Chart
Since August 11, 2000, Compugen's market cap has increased from 289.89M to 503.86M, an increase of 73.81%. That is a compound annual growth rate of 2.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 503.86M | 10.44% |
| Dec 31, 2025 | 456.23M | -8.56% |
| Dec 31, 2024 | 498.96M | -20.78% |
| Dec 29, 2023 | 629.82M | 188.91% |
| Dec 30, 2022 | 218.00M | -81.09% |
| Dec 31, 2021 | 1.15B | -64.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 532.57M |
| Geffen Residence & Renewal | 255.15M |
| Matricelf | 153.51M |
| Clal Biotechnology Industries | 48.78M |
| BioLineRx | 41.77M |
| BioLight Life Sciences | 33.24M |
| Evogene | 27.34M |
| XTL Biopharmaceuticals | 25.55M |